People_

Professor Roger Reddel

BSc(Med), MBBS, FRACP, PhD, FAAHMS, FAA

Sir Lorimer Dods Professor, Faculty of Medicine and Health
Director, Children's Medical Research Institute (CMRI)
Head, Cancer Research Unit, CMRI

Phone

+61 2 8865 2901

Fax

+61 2 8865 2860

roger.reddel@sydney.edu.au

Websites

CMRI website

Biographical details

Professor Roger Reddel AO is a medical oncologist, molecular geneticist and an internationally renowned expert on cancer cell immortalisation. He is Director of Children’s Medical Research Institute (CMRI), Westmead, a Fellow of the Australian Academy of Science, and a Fellow of the Australian Academy of Health and Medical Sciences. His research career on the cellular and molecular biology of immortalisation commenced as a postdoctoral scientist (Fulbright Fellow) at the National Cancer Institute, Maryland, USA, where he improved techniques for immortalisation of human cells in vitro and made the key finding that immortalisation is necessary for malignant transformation of human cells. He returned to Australia to establish and head the Cancer Research Unit at CMRI, with a fellowship from Cancer Council NSW, which provided major support for three decades. He is internationally recognised for research on the enzyme telomerase and for discovering ALT (Alternative Lengthening of Telomeres), which together contribute to unlimited growth in >95% of cancers. His team has made additional seminal findings regarding ALT and the manner in which it is repressed in normal (non-cancer) cells, and identified a molecular marker for ALT. Overall his research aims to help develop anti-cancer treatments that would work by blocking immortalisation, and tests for detecting signs of cellular immortalisation for early detection of cancer. Professor Reddel has won numerous awards including the Ramaciotti Medal for Excellence in Biomedical Research (2007), the 2011 NSW Premier's Award for Outstanding Cancer Researcher of the Year, and the Neil Hamilton Fairley Medal of the Royal Australasian College of Physicians (2017). He was a founding member of the University of Sydney's Cancer Research Network and chaired its Translational Research Committee. He is a member of the Board of Luminesce Alliance, which has been set up to coordinate paediatric research in NSW..

Research interests

Professor Reddel’s research on the molecular genetics of cancer cell immortalisation focuses on the processes by which telomeres in cancer cells remain lengthened thereby facilitating evasion of senescence, i.e. studies on the enzyme telomerase and an alternative mechanism of lengthening of telomeres (ALT). The latter field of research was created after his team’s discovery of ALT in human cell lines, tumour-derived cell lines and in tumours. His team has since made major findings including: the discovery of a novel type of PML body in ALT cells that enables diagnosis of ALT by immunostaining of routine tumour sections; demonstration of ALT activation due to loss of repressor gene(s); cloning of the human telomerase catalytic subunit, hTERT (with an Australian consortium led by Dr Andrzej Kilian, Canberra); first definitive identification of the subunits of active human telomerase enzyme; showing that the presence of ALT activity is a strong predictor of outcome for high-grade brain tumours; and discovery of a molecular marker that is rapidly responsive to changes in ALT activity.

Ongoing research remains focused on investigating the molecular mechanisms of ALT and how it is repressed in normal cells, finding the counterpart of ALT in normal tissues, developing assays to help identify ALT-inhibiting drugs, optimising methods for ALT detection in tumours (for routine use in pathology laboratories), and studies of the prevalence and prognostic significance of ALT in human cancer.

With Professor Phil Robinson, he founded and directs the Australian Cancer Research Foundation International Centre for the Proteome of Human Cancer (ProCan^R), which is a large multidisciplinary research program developing the technology and evidence base required to utilise cancer tissue proteomic data in the cancer clinic.

Associations

American Association for Cancer Research

Australian and New Zealand Children's Haematology/Oncology Group

Australian Society for Biochemistry and Molecular Biology

Australian Society for Medical Research

Australian and New Zealand Society for Cell and Developmental Biology

European Association for Cancer Research

Australasian Sarcoma Study Group

Awards and honours

Officer of the Order of Australia (AO) 2021

Neil Hamilton Fairley Medal of Royal Australasian College of Physicians 2017

Fellow of Australian Academy of Health and Medical Sciences 2017

Premier's Award for Outstanding Cancer Researcher of the Year 2011

Fellow of Australian Academy of Science 2010

Ramaciotti Medal for Excellence in Biomedical Research 2007

NHMRC Senior Principal Research Fellowship, 2004-2007

Rotary Australia Award for Vocational Excellence, 2003

Aspen Cancer Conference Young Investigator Award, July 1987

Fulbright Postdoctoral Fellowship, 1984-1985

C. J. Martin Fellowship of the National Health and Medical Research Council, Australia, 1984-1986

Harry J. Clayton Memorial Prize for Medicine and Clinical Medicine, University of Sydney, 1976

Harold John Ritchie Memorial Prize (shared) for Medicine, University of Sydney, 1976

Cedric Swanton Memorial Prize for Psychiatry (shared), University of Sydney, 1975

Peter Bancroft Prize (shared) for best undergraduate or postgraduate research in Faculty of Medicine, University of Sydney, 1974

Themes

Cancer

Keywords

Proteomics, Cellular immortalisation, Cellular senescence, tumour suppressor genes, Telomeres

Approaches

Cellular/Molecular, Genetics

Clinical speciality

Oncology

Current research students

Project title	Research student
Investigating the Utility of Using Proteomics for Clinical Based Cancer Applications	Emma BOYS

Publications

By Type

Expand all

Book Chapters

Pickett, H., Reddel, R. (2009). Alternative lengthening of telomeres in human cells. In Keiko Hiyama (Eds.), Telomeres and Telomerase in Cancer, (pp. 127-148). New York: Springer. [More Information]
Jiang, W., Henson, J., Neumann, A., Reddel, R. (2009). Protocol III: Detection of alternative lengthening of telomeres. In Keiko Hiyama (Eds.), Telomeres and Telomerase in Cancer, (pp. 351-364). New York: Springer. [More Information]
Cesare, A., Reddel, R. (2008). Alternative Lengthening of Telomeres in Mammalian Cells. In Josef Nosek and Lubomir Tomaska (Eds.), Origin and Evolution of Telomeres, (pp. 45-57). United States: Landes Biosciences.
Neumann, A., Reddel, R. (2006). Telomerase independent maintenance of mammalian telomeres. In Titia De Lange, Vicki Lundblad, Elizabeth H. Blackburn (Eds.), Telomeres and Telomerase, (pp. 163-198). Michigan: Cold Spring Harbor Laboratory Press.
Toouli, C., Reddel, R. (2003). Telomeres and cellular ageing. In S.C. Kaul and R. Wadhwa (Eds.), Aging of Cells In and Outside the Body, (pp. 171-205). US: Kluwer Academic Publishers.
Fasching, C., Reddel, R. (2002). Telomere maintenance in human cell lines and tumors without telomerase. In Guido Krupp and Reza Parwaresch (Eds.), Telomeres and telomerases: Cancer and Biology, (pp. 359-373). Georgetown, Texas, USA: Landes Biosciences.

show 3 more

Journals

Zhong, Q., Sun, R., Aref, A., Noor, Z., Anees, A., Zhu, Y., Lucas, N., Poulos, R., Lyu, M., Zhu, T., Hains, P., Reddel, R., Robinson, P., et al (2024). Proteomic-based stratification of intermediate-risk prostate cancer patients. Life Science Alliance, 7(2). [More Information]
Boys, E., Gao, B., Grimison, P., Sutherland, S., MacKenzie, K., Reddel, R., Liu, J. (2024). Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia. Cancer Medicine, 13(6). [More Information]
Kienzl, P., Weber, G., Pirker, C., Laengle, S., Braunschmid, T., Dragona, E., Marian, B., Gagos, S., Lu, L., Henson, J., Lau, L., Reddel, R., et al (2024). Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression. Cellular Oncology. [More Information]
Boys, E., Liu, J., Robinson, P., Reddel, R. (2023). Clinical applications of mass spectrometry-based proteomics in cancer: Where are we? Proteomics, 23(2023-08-07 00:00:00). [More Information]
Tuano, N., Beesley, J., Manning, M., Shi, W., Perlaza-Jimenez, L., Malaver-Ortega, L., Paynter, J., Black, D., Civitarese, A., McCue, K., Reddel, R., et al (2023). CRISPR screens identify gene targets at breast cancer risk loci. Genome Biology, 24(1). [More Information]
Poulos, R., Cai, Z., Robinson, P., Reddel, R., Zhong, Q. (2023). Opportunities for pharmacoproteomics in biomarker discovery. Proteomics, 23(7-8). [More Information]
Connolly, E., Grimison, P., Horvath, L., Robinson, P., Reddel, R. (2023). Quantitative proteomic studies addressing unmet clinical needs in sarcoma. Frontiers in Oncology, 13. [More Information]
Holmes, O., Nones, K., Tang, Y., Loffler, K., Lee, M., Patch, A., Dagg, R., Lau, L., Leonard, C., Wood, S., Pickett, H., Reddel, R., et al (2022). qmotif: determination of telomere content from whole-genome sequence data. Bioinformatics Advances, 2(1). [More Information]
Reddel, R., Aref, A. (2022). Targeting brain cancer. Science, 377(6605), 467-468. [More Information]
de Nonneville, A., Salas, S., Bertucci, F., Sobinoff, A., Adélaïde, J., Guille, A., Finetti, P., Noble, J., Churikov, D., Chaffanet, M., Pickett, H., Reddel, R., et al (2022). TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. EMBO Molecular Medicine, 14(10). [More Information]
de Nonneville, A., Reddel, R. (2021). Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX. Nature Communications, 12(1), 1552. [More Information]
Kaul, Z., Cheung, C., Bhargava, P., Sari, A., Yu, Y., Huifu, H., Bid, H., Henson, J., Groden, J., Reddel, R., et al (2021). Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells. Scientific Reports, 11(1), 17052. [More Information]
Chen, Y., Dagg, R., Zhang, Y., Lee, J., Lu, R., la Rotta, N., Sampl, S., Korkut-Demirbaş, M., Holzmann, K., Lau, L., Reddel, R., et al (2021). The c-circle biomarker is secreted by alternative-lengthening-of-telomeres positive cancer cells inside exosomes and provides a blood-based diagnostic for alt activity. Cancers, 13(21), 5369. [More Information]
Reddel, R., MacKenzie, K., Bryan, T. (2020). End Products of Telomere Research. Cell Stem Cell, 26(6), 804-805. [More Information]
Kamata, T., So, T., Ahmed, Q., Giblett, S., Patel, B., Luo, J., Reddel, R., Pritchard, C. (2020). Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development. Cell Reports, 31(12), 107802. [More Information]
Eiholzer, R., Mehta, S., Kazantseva, M., Drummond, C., McKinney, C., Young, K., Slater, D., Morten, B., Avery-Kiejda, K., Lasham, A., Reddel, R., Huschtscha, L., et al (2020). Intronic TP53 polymorphisms are associated with increased change 133TP53 transcript, immune infiltration and cancer risk. Cancers, 12(9), 1-18. [More Information]
Wu, Y., Poulos, R., Reddel, R. (2020). Role of POT1 in Human Cancer. Cancers, 12(10), 1-19. [More Information]
Poulos, R., Hains, P., Shah, R., Lucas, N., Xavier, D., Manda, S., Anees, A., Koh, J., Mahboob, S., Wittman, M., Williams, S., Sykes, E., Hecker, M., Dausmann, M., Wouters, M., Yang, J., deFazio, A., Balleine, R., Tully, B., Reddel, R., Robinson, P., Zhong, Q., et al (2020). Strategies to enable large-scale proteomics for reproducible research. Nature Communications, 11(1), 3793. [More Information]
Tully, B., Balleine, R., Hains, P., Zhong, Q., Reddel, R., Robinson, P. (2019). Addressing the Challenges of High-Throughput Cancer Tissue Proteomics for Clinical Application: ProCan. Proteomics, 19(21-22), 1-5. [More Information]
HAN, M., Napier, C., Frolich, S., Teber, E., Wong, T., Noble, J., Choi, E., Everett, R., Cesare, A., Reddel, R. (2019). Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency. Journal of Cell Science, 132(5), 1-10. [More Information]
Lu, R., O'Rourke, J., Sobinoff, A., Allen, J., Nelson, C., Tomlinson, C., Lee, M., Reddel, R., Deans, A., Pickett, H. (2019). The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT). Nature Communications, 10(1), 1-14. [More Information]
Campbell, H., Fleming, N., Roth, I., Mehta, S., Wiles, A., Williams, G., Vennin, C., Arsic, N., Parkin, A., Pajic, M., Reddel, R., Braithwaite, A., et al (2018). delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling. Nature Communications, 9, 1-13. [More Information]
Nair, S., Luu, P., Qu, W., Maddugoda, M., Huschtscha, L., Reddel, R., Chenevix-Trench, G., Toso, M., Kench, J., Horvath, L., Hayes, V., Rasko, J., Wong, J., et al (2018). Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten. Epigenetics & Chromatin, 11(1), 1-20. [More Information]
Mehta, S., Morten, B., Anthony, J., Henderson, L., Lasham, A., Campbell, H., Cunliffe, H., Horsfield, J., Reddel, R., Avery-Kiejda, K., Braithwaite, A., et al (2018). Regulation of the interferon-gamma (IFN-y) pathway by p63 and 133p53 isoform in different breast cancer subtypes. Oncotarget, 9(49), 29146-29161. [More Information]
Lee, M., Teber, E., Holmes, O., Nones, K., Patch, A., Dagg, R., Lau, L., Lee, J., Napier, C., Arthur, J., Hayward, N., Mann, G., Scolyer, R., Wilmott, J., Reddel, R., Pickett, H., et al (2018). Telomere sequence content can be used to determine ALT activity in tumours. Nucleic Acids Research, 46, 4903-4918. [More Information]
Sobinoff, A., Allen, J., Neumann, A., Yang, S., Walsh, M., Henson, J., Reddel, R., Pickett, H. (2017). BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres. EMBO Journal, 36(19), 2907-2919. [More Information]
Lee, M., Napier, C., Yang, F., Arthur, J., Reddel, R., Pickett, H. (2017). Comparative analysis of whole genome sequencing-based telomere length measurement techniques. Methods, 114, 4-15. [More Information]
Dagg, R., Pickett, H., Neumann, A., Napier, C., Henson, J., Teber, E., Arthur, J., Reynolds, C., Murray, J., Haber, M., Sobinoff, A., Lau, L., Reddel, R. (2017). Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres. Cell Reports, 19(12), 2544-2556. [More Information]
Helbig, S., Wockner, L., Bouendeu, A., Hille-Betz, U., McCue, K., French, J., Edwards, S., Pickett, H., Reddel, R., Chenevix-Trench, G., et al (2017). Functional dissection of breast cancer risk-associated TERT promoter variants. Oncotarget, 8(40), 67203-67217. [More Information]
Ginn, S., Hallwirth, C., Liao, S., Teber, E., Arthur, J., Wu, J., Lee, H., Tay, S., Hu, M., Reddel, R., Alexander, S., Alexander, I., et al (2017). Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency. Molecular Therapy - Nucleic Acids, 6, 1-14. [More Information]
Khushi, M., Napier, C., Smyth, C., Reddel, R., Arthur, J. (2017). MatCol: A tool to measure fluorescence signal colocalisation in biological systems. Scientific Reports, 7(1), 1-9. [More Information]
Henson, J., Lau, L., Koch, S., Martin La Rotta, N., Dagg, R., Reddel, R. (2017). The C-Circle Assay for Alternative-Lengthening-of-Telomeres activity. Methods, 114, 74-84. [More Information]
Scarpa, A., Chang, D., Nones, K., Corbo, V., Patch, A., Bailey, P., Lawlor, R., Johns, A., Miller, D., Lau, L., Lee, M., Pickett, H., Reddel, R., Samra, J., Kench, J., Gill, A., et al (2017). Whole-genome landscape of pancreatic neuroendocrine tumours. Nature, 543(7643), 65-71. [More Information]
Yu, Y., Katiyar, S., Sundar, D., Kaul, Z., Miyako, E., Zhang, Z., Kaul, S., Reddel, R., Wadhwa, R. (2017). Withaferin-A kills cancer cells with and without telomerase: Chemical, computational and experimental evidences. Cell Death and Disease, 8(4), 1-12. [More Information]
Mehta, S., Tsai, P., Lasham, A., Campbell, H., Reddel, R., Braithwaite, A., Print, C. (2016). A study of TP53 RNA splicing illustrates pitfalls of RNA-seq methodology. Advances in Cancer Research, 76(24), 7151-7159. [More Information]
Novakovic, B., Napier, C., Vryer, R., Dimitriadis, E., Manuelpillai, U., Sharkey, A., Craig, J., Reddel, R., Saffery, R. (2016). DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta. Molecular Human Reproduction, 22(11), 791-799. [More Information]
Shannon, M., Capes-Davis, A., Eggington, E., Georghiou, R., Huschtscha-Holliday, L., Moy, E., Power, M., Reddel, R., Arthur, J. (2016). Is cell culture a risky business? Risk analysis based on scientist survey data. International Journal of Cancer, 138(3), 664-670. [More Information]
Barbaro, P., Ziegler, D., Reddel, R. (2016). The wide-ranging clinical implications of the short telomere syndromes. Internal Medicine Journal, 46(4), 393-403. [More Information]
Killedar, A., Stutz, M., Sobinoff, A., Tomlinson, C., Bryan, T., Beesley, J., Chenevix-Trench, G., Reddel, R., Pickett, H. (2015). A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase. PLoS Genetics, 11(6), 1-23. [More Information]
Napier, C., Huschtscha-Holliday, L., Harvey, A., Bower, K., Noble, J., Hendrikson, E., Reddel, R. (2015). ATRX represses alternative lengthening of telomeres. Oncotarget, 6(18), 16543-16558. [More Information]
Locke, W., Zotenko, E., Stirzaker, C., Robinson, M., Hinshelwood, R., Stone, A., Reddel, R., Huschtscha, L., Clark, S. (2015). Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis. Clinical Epigenetics, 7(1), 1-15. [More Information]
Pickett, H., Reddel, R. (2015). Molecular mechanisms of activity and derepression of alternative lengthening of telomeres. Nature Structural and Molecular Biology, 22(11), 875-880. [More Information]
Pan, J., Huang, L., Belousova, T., Lu, L., Yang, Y., Reddel, R., Chang, A., Ju, H., DiMattia, G., Tong, Q., et al (2015). Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway. Journal of the American Society of Nephrology, 26(2), 364-378. [More Information]
Chang, A., Doherty, J., Huschtscha-Holliday, L., Redvers, R., Restall, C., Reddel, R., Anderson, R. (2015). STC1 expression is associated with tumor growth and metastasis in breast cancer. Clinical and Experimental Metastasis, 32(1), 15-27. [More Information]
Guo, Y., Kartawinata, M., Li, J., Pickett, H., Teo, J., Kilo, T., Barbaro, P., Keating, B., Chen, Y., Tian, L., Al-Odaib, A., Reddel, R., Christodoulou, J., Bryan, T., et al (2014). Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood, 124(18), 2767-2774. [More Information]
Singh, R., Kalra, R., Hasan, K., Kaul, Z., Cheung, C., Huschtscha, L., Reddel, R., Kaul, S., Wadhwa, R. (2014). Molecular characterization of collaborator of ARF (CARF) as a DNA damage response and cell cycle checkpoint regulatory protein. Experimental Cell Research, 322(2), 324-334. [More Information]
Conomos, D., Reddel, R., Pickett, H. (2014). NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. Nature Structural and Molecular Biology, 21(9), 760-770. [More Information]
Gupta, R., Dong, Y., Solomon, P., Wettersten, H., Cheng, C., Min, J., Henson, J., Dogra, S., Hwang, S., Hammock, B., Reddel, R., et al (2014). Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A. Proceedings of the National Academy of Sciences of the United States of America, 111(30), E3062-E3071. [More Information]
Lee, M., Hills, M., Conomos, D., Stutz, M., Dagg, R., Lau, L., Reddel, R., Pickett, H. (2014). Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes. Nucleic Acids Research, 42(3), 1733-1746. [More Information]
Reddel, R. (2014). Telomere maintenance mechanisms in cancer: clinical implications. Current Pharmaceutical Design, 20(41), 6361-6374. [More Information]
Neumann, A., Watson, C., Noble, J., Pickett, H., Tam, P., Reddel, R. (2013). Alternative lengthening of telomeres in normal mammalian somatic cells. Genes and Development, 27(1), 18-23. [More Information]
Conomos, D., Pickett, H., Reddel, R. (2013). Alternative lengthening of telomeres: remodeling the telomere architecture. Frontiers in Oncology, 3, 1-7. [More Information]
Lau, L., Dagg, R., Henson, J., Au, A., Royds, J., Reddel, R. (2013). Detection of alternative lengthening of telomeres by telomere quantitative PCR. Nucleic Acids Research, 41(2), 1-9. [More Information]
Bojesen, S., Pooley, K., Johnatty, S., Beesley, J., Michailidou, K., Tyrer, J., Edwards, S., Pickett, H., Shen, H., Smart, C., Stutz, M., Reddel, R., et al (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics, 45(4), 371-384. [More Information]
Durukan Tolvanen, A., Westberg, J., Serlachius, M., Chang, A., Reddel, R., Andersson, L., Tatlisumak, T. (2013). Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance. Neuroscience, 229, 49-54. [More Information]
Pena, C., Cespedes, M., Lindh, M., Kiflemariam, S., Mezheyeuski, A., Edqvist, P., Hagglof, C., Birgisson, H., Bojmar, L., Jirstrom, L., Chang, A., Reddel, R., et al (2013). STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer. Cancer Research, 73(4), 1287-1297. [More Information]
Shay, J., Reddel, R., Wright, W. (2012). Cancer and Telomeres - An ALTernative to Telomerase. Science, 336(6087), 1388-1390. [More Information]
Huschtscha-Holliday, L., Napier, C., Noble, J., Bower, K., Au, A., Campbell, H., Braithwaite, A., Reddel, R. (2012). Enhanced isolation of fibroblasts from human skin explants. BioTechniques, 53(4), 239-244. [More Information]
Bender, H., Murchison, E., Pickett, H., Deakin, J., Strong, M., Conlan, C., McMillan, D., Neumann, A., Greider, C., Hannon, G., Reddel, R., et al (2012). Extreme telomere length dimorphism in the Tasmanian devil and related marsupials suggests parental control of telomere length. PloS One, 7(9), 1-10. [More Information]
Kaul, Z., Cesare, A., Huschtscha-Holliday, L., Neumann, A., Reddel, R. (2012). Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Reports, 13(1), 52-59. [More Information]
Lovejoy, C., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., De Lange, T., De, S., Petrini, J., Sung, P., Jasin, M., Reddel, R., et al (2012). Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway. PLoS Genetics, 8(7), 1-16. [More Information]
Bower, K., Napier, C., Cole, S., Dagg, R., Lau, L., Duncan, E., Moy, E., Reddel, R. (2012). Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres. PloS One, 7(11), 1-10. [More Information]
Pickett, H., Reddel, R. (2012). The role of telomere trimming in normal telomere length dynamics. Cell Cycle, 11(7), 1309-1315. [More Information]
Conomos, D., Stutz, M., Hills, M., Neumann, A., Bryan, T., Reddel, R., Pickett, H. (2012). Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells. The Journal of Cell Biology, 199(6), 893-906. [More Information]
Beesley, J., Pickett, H., Johnatty, S., Dunning, A., Chen, X., Li, J., Michailidou, K., Lu, Y., Rider, D., Palmieri, R., Stutz, M., Reddel, R., et al (2011). Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PloS One, 6(9), 1-6. [More Information]
Jiang, W., Nguyen, A., Cao, Y., Chang, A., Reddel, R. (2011). HP1-Mediated Formation of Alternative Lengthening of Telomeres-Associated PML Bodies Requires HIRA but Not ASF1a. PloS One, 6(2), e17036-1-e17036-12. [More Information]
Yoon, A., Gao, R., Kaul, Z., Choi, I., Ryu, J., Noble, J., Kato, Y., Saito, S., Hirano, T., Ishii, T., Reddel, R., et al (2011). MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region. Nucleic Acids Research, 39(18), 8078-8091. [More Information]
Pickett, H., Henson, J., Au, A., Neumann, A., Reddel, R. (2011). Normal mammalian cells negatively regulate telomere length by telomere trimming. Human Molecular Genetics, 20(23), 4684-4692. [More Information]
Au, A., Hackl, T., Yeager, T., Cohen, S., Pass, H., Harris, C., Reddel, R. (2011). Telomerase activity in pleural malignant mesotheliomas. Lung Cancer, 73(3), 283-288. [More Information]
Cesare, A., Reddel, R. (2010). Alternative lengthening of telomeres: models, mechanisms and implications. Nature reviews. Genetics, 11(5), 319-30. [More Information]
Henson, J., Reddel, R. (2010). Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. FEBS Letters, 584(17), 3800-11. [More Information]
Capes-Davis, A., Atkin, I., Drexler, H., Kohara, A., Macleod, R., Masters, J., Nakamura, Y., Reid, Y., Reddel, R., Freshney, R. (2010). Check your cultures! A list of cross-contaminated or misidentified cell lines. International Journal of Cancer, 127(1), 1-8. [More Information]
McDonald, K., McDonnell, J., Muntoni, A., Henson, J., Hegi, M., von Deimling, A., Wheeler, H., Cook, R., Biggs, M., Little, N., Robinson, B., Reddel, R., et al (2010). Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival. Journal of Neuropathology and Experimental Neurology, 69(7), 729-736. [More Information]
Reddel, R. (2010). Senescence: an antiviral defense that is tumor suppressive? Carcinogenesis, 31(1), 19-26. [More Information]
Hinshelwood, R., Melki, J., Huschtscha, L., Paul, C., Song, J., Stirzaker, C., Reddel, R., Clark, S. (2009). Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Human Molecular Genetics, 18(16), 3098-3109. [More Information]
Pickett, H., Cesare, A., Johnston, R., Neumann, A., Reddel, R. (2009). Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO Journal, 28(7), 799-809. [More Information]
Henson, J., Cao, Y., Huschtscha-Holliday, L., Chang, A., Au, A., Pickett, H., Reddel, R. (2009). DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nature Biotechnology, 27(12), 1181-1185. [More Information]
Graham, J., Mote, P., Salagame, U., Van Dijk, J., Balleine, R., Huschtscha-Holliday, L., Reddel, R., Clarke, C. (2009). DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology, 150(7), 3318-3326. [More Information]
Jiang, W., Zhong, Z., Nguyen, A., Henson, J., Toouli, C., Braithwaite, A., Reddel, R. (2009). Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. The Journal of Cell Biology, 185(5), 797-810. [More Information]
Huschtscha-Holliday, L., Moore, J., Noble, J., Campbell, H., Royds, J., Braithwaite, A., Reddel, R. (2009). Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21WAF1/CIP1. Journal of Cell Science, 122(16), 2989-2995. [More Information]
Cesare, A., Kaul, Z., Cohen, S., Napier, C., Pickett, H., Neumann, A., Reddel, R. (2009). Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nature Structural and Molecular Biology, 16(12), 1244-1251. [More Information]
Nguyen, A., Chang, A., Reddel, R. (2009). Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress. Oncogene, 28(18), 1982-1992. [More Information]
Ng, L., Cropley, J., Pickett, H., Reddel, R., Suter, C. (2009). Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Research, 37(4), 1152-1159. [More Information]
Muntoni, A., Neumann, A., Hills, M., Reddel, R. (2009). Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres. Human Molecular Genetics, 18(6), 1017-1027. [More Information]
Yuan, J., Yang, B., Zhong, Z., Shatts, I., Milyavski, M., Rotter, V., Lock, R., Reddel, R., Mackenzie, K. (2009). Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase. Oncogene, 28(29), 2678-2689. [More Information]
Cohen, S., Reddel, R. (2008). A sensitive direct human telomerase activity assay. Nature Methods, 5(4), 355-360. [More Information]
Cao, Y., Huschtscha-Holliday, L., Nouwens, A., Pickett, H., Neumann, A., Chang, A., Toouli, C., Bryan, T., Reddel, R. (2008). Amplification of Telomerase Reverse Transcriptase Gene in Human Mammary Epithelial Cells with Limiting Telomerase RNA Expression Levels. Cancer Research, 68(9), 3115-3123. [More Information]
Cao, Y., Bryan, T., Reddel, R. (2008). Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Science, 99(6), 1092-1099. [More Information]
Villa, R., Daidone, M., Motta, R., Venturini, L., De Marco, C., Vannelli, A., Kusamura, S., Baratti, D., Deraco, M., Costa, A., Reddel, R., et al (2008). Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clinical Cancer Research, 14(13), 4134-4140. [More Information]
Chen, Y., Campbell, H., Wiles, A., Eccles, M., Reddel, R., Braithwaite, A., Royds, J. (2008). PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma. Cancer Research, 68(14), 5724-5732. [More Information]
Cesare, A., Reddel, R. (2008). Telomere uncapping and alternative lengthening of telomeres. Mechanisms of Ageing and Development, 129(1-2), 99-108. [More Information]
Chang, A., Hook, J., Lemckert, F., McDonald, M., Nguyen, M., Hardeman, E., Little, D., Gunning, P., Reddel, R. (2008). The murine stanniocalcin 2 gene is a negative regulator of postnatal growth. Endocrinology, 149(5), 2403-2410. [More Information]
Reddel, R. (2007). A SUMO ligase for ALT. Nature Structural and Molecular Biology, 14(7), 570-571. [More Information]
Hinshelwood, R., Huschtscha-Holliday, L., Melki, J., Stirzaker, C., Abdipranoto, A., Vissel, B., Ravasi, T., Wells, C., Hume, D., Reddel, R., et al (2007). Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Cancer Research, 67(24), 11517-11527. [More Information]
Zhong, Z., Jiang, W., Cesare, A., Neumann, A., Wadhwa, R., Reddel, R. (2007). Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. Journal of Biological Chemistry, 282(40), 29314-29322. [More Information]
Fasching, C., Neumann, A., Muntoni, A., Yeager, T., Reddel, R. (2007). DNA Damage Induces Alternative Lengthening of Telomeres (ALT) Associated Promyelocytic Leukemia Bodies that Preferentially Associate with Linear Telomeric DNA. Cancer Research, 67(15), 7072-7077. [More Information]
Jiang, W., Zhong, Z., Henson, J., Reddel, R. (2007). Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene, 26(32), 4635-4647. [More Information]
Cohen, S., Graham, M., Lovrecz, G., Bache, N., Robinson, P., Reddel, R. (2007). Protein composition of catalytically active human telomerase from immortal cells. Science, 315(5820), 1850-1853. [More Information]
Chen, Y., Hakin-Smith, V., Teo, M., Xinarianos, G., Jellinek, D., Carroll, T., McDowell, D., MacFarlane, M., Boet, R., Baguley, B., Braithwaite, A., Reddel, R., et al (2006). Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma. Cancer Research, 66(13), 6473-6476. [More Information]
Costa, A., Daidone, M., Daprai, L., Villa, R., CantÃ¹, S., Pilotti, S., Mariani, L., Gronchi, A., Henson, J., Reddel, R., et al (2006). Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Research, 66(17), 8918-8924. [More Information]
Wadhwa, R., Takano, S., Kaur, K., Deocaris, C., Pereira-Smith, O., Reddel, R., Kaul, S. (2006). Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. International Journal of Cancer, 118(12), 2973-2980. [More Information]
Henson, J., Hannay, J., McCarthy, S., Royds, J., Yeager, T., Robinson, R., Wharton, S., Jellinek, D., Arbuckle, S., Yoo, J., Robinson, B., Learoyd, D., Reddel, R., et al (2005). A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clinical Cancer Research, 11(1), 217-225. [More Information]
Jeyapalan, J., Varley, H., Foxon, J., Pollock, R., Jeffreys, A., Henson, J., Reddel, R., Royle, N. (2005). Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome. Human Molecular Genetics, 14(13), 1785-1794. [More Information]
Moran-Jones, K., Wayman, L., Kennedy, D., Reddel, R., Sara, S., Snee, M., Smith, R. (2005). hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Research, 33(2), 486-496. [More Information]
Jiang, W., Zhong, Z., Henson, J., Neumann, A., Chang, A., Reddel, R. (2005). Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex. Molecular and Cellular Biology, 25(7), 2708-2721. [More Information]
Fasching, C., Bower, K., Reddel, R. (2005). Telomerase-Independent Telomere Length Maintenance in the Absence of Alternative Lengthening of Telomeresâ€“Associated Promyelocytic Leukemia Bodies. Cancer Research, 65(7), 2722-2729. [More Information]
Muntoni, A., Reddel, R. (2005). The first molecular details of ALT in human tumor cells. Human Molecular Genetics, 14(Review Issue 2), R191-R196. [More Information]
Chang, A., Cha, J., Koentgen, F., Reddel, R. (2005). The murine stanniocalcin 1 gene is not essential for growth and development. Molecular and Cellular Biology, 25(23), 10604-10610. [More Information]
Noble, J., Zhong, Z., Neumann, A., Melki, J., Clark, S., Reddel, R. (2004). Alterations In The P16(Ink4A) And P53 Tumor Suppressor Genes Of Htert-Immortalized Human Fibroblasts. Oncogene, 23(17), 3116-3121. [More Information]
Londono-Vallejo, J., Der-Sarkissian, H., Cazes, L., Bacchetti, S., Reddel, R. (2004). Alternative Lengthening Of Telomeres Is Characterized By High Rates Of Telomeric Exchange. Cancer Research, 64(7), 2324-2327. [More Information]
Colgin, L., Reddel, R. (2004). Telomere Biology: A New Player In The Dispatch End Zone. Current Biology, 14(20), R901-R902. [More Information]
Hakin-Smith, V., Jellinek, D., Levy, D., Carroll, T., Teo, M., Timperley, W., McKay, M., Reddel, R., Royds, J. (2003). Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. The Lancet, 361(9360), 836-838. [More Information]
Reddel, R. (2003). Alternative lengthening of telomeres, telomerase and cancer. Cancer Letters, 194(2), 155-162. [More Information]
Reddel, R., Bryan, T. (2003). Alternative lengthening of telomeres: dangerous road less travelled. The Lancet, 361(9372), 1840-1841. [More Information]
Colgin, L., Baran, K., Baumann, P., Cech, T., Reddel, R. (2003). Human POT1 facilitates telomere elongation by telomerase. Current Biology, 13(11), 942-946. [More Information]
Chang, A., Jellinek, D., Reddel, R. (2003). Mammalian stanniocalcins and cancer. Endocrine-Related Cancer, 10(3), 359-373. [More Information]
Kaul, S., Yaguchi, T., Taira, K., Reddel, R., Wadhwa, R. (2003). Overexpressed mortalin (mot-2)/mthsp70/GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts. Experimental Cell Research, 286(1), 96-101. [More Information]
Wadhwa, R., Sugihara, T., Hasan, M., Taira, K., Reddel, R., Kaul, S. (2002). A Major Functional Difference between the mouse and Human ARF Tumor Suppressor proteins. Journal of Biological Chemistry, 277(39), 36665-36670. [More Information]
Henson, J., Neumann, A., Yeager, T., Reddel, R. (2002). Alternative lengthening of telomeres in mammalian cells. Oncogene, 21(4), 598-610. [More Information]
Toouli, C., Huschtscha-Holliday, L., Neumann, A., Noble, J., Colgin, L., Hukku, B., Reddel, R. (2002). Comparison of human mammary epithelial cells immortalized by simian virus 40 T-antigen or by the telomerase catalytic subunit. Oncogene, 21(1), 128-139. [More Information]
Wadhwa, R., Yaguchi, T., Hasan, M., Mitsui, Y., Reddel, R., Kaul, S. (2002). Hsp70 Family Member, mot-2/mthsp70/GRP75, binds to the Cytoplasmic Sequestration Domain of the P53 Gene. Experimental Cell Research, 274(2), 246-253. [More Information]
Varley, H., Pickett, H., Foxon, J., Reddel, R., Royle, N. (2002). Molecular characterisation of inter-telomere and intra-telomere mutations in human ALT cells. Nature Genetics, 30(3), 301-305. [More Information]
Wadhwa, R., Colgin, L., Yaguchi, T., Taira, K., Reddel, R., Kaul, S. (2002). Rhodacyanine Dye MKT-077 Inhibits in Vito Telomerase Assay but has no detectable effects on Telomerase activity in vivo. Cancer Research, 62(15), 4434-4438.
Bouras, T., Southey, M., Chang, A., Reddel, R., Willhite, D., Glynne, R., Henderson, M., Armes, J., Venter, D. (2002). Stanniocalcin 2 is an estorgen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Research, 62(5), 1289-1295.
Neumann, A., Reddel, R. (2002). Telomere maintenance and cancer - look, no Telomerase. Nature Reviews Cancer, 2(11), 879-884. [More Information]
Reddel, R., Bryan, T., Colgin, L., Perrem, K., Yeager, T. (2001). Alternative lengthening of telomeres in human cells. Radiation Research, 155(1), 194-200. [More Information]
Reddel, R. (2001). An alternative lifestyle for immortalized oral keratinocytes. Journal of Clinical Investigation, 108, 665-667.
Reddel, R., Kaul, S., Mitsui,, Y., Wadhwa, R. (2001). An N-Terminal Region of Mot-2 Binds to p53 In Vitro. Neoplasia (Spanish Edition): oncologia multidisciplinaria, 3, 110-114.
Perrem, K., Colgin, L., Neumann,, A., Yeager, T., Reddel, R. (2001). Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells. Molecular and Cellular Biology, 21, 3862-3875.
Reddel, R., Huschtscha, L., Neumann,, A., Noble,, J. (2001). Effects of Simian Virus 40 T-Antigens on Normal Human Mammary Epithelial Cells Reveal Evidence for Spontaneous Alterations in Addition to Loss of P16INK4a Expression. Experimental Cell Research, 265, 125-134.
Reddel, R., Sugihara, T., Kaul, S., Kato, J., Nomura, H., Wadhwa, R. (2001). Pex19p Dampens the p19ARF-p53-p21WAF1 Tumor Suppressor Pathway. Journal of Biological Chemistry, 276, 18649-18652.
Reddel, R., Szutorisz, H., Palmqvist, R., Roos, G., Stenling,, R., Schorderet, D., Linger,, J., Nabholz,, M. (2001). Rearrangements of minisatelites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas. Oncogene, 20, 2600-2605.

show 129 more

Reference Works

Reddel, R. (2012). Senescence and immortalization. (Vol. 1, pp. 2697-2699).

By Year

Expand all

2024

Zhong, Q., Sun, R., Aref, A., Noor, Z., Anees, A., Zhu, Y., Lucas, N., Poulos, R., Lyu, M., Zhu, T., Hains, P., Reddel, R., Robinson, P., et al (2024). Proteomic-based stratification of intermediate-risk prostate cancer patients. Life Science Alliance, 7(2). [More Information]
Boys, E., Gao, B., Grimison, P., Sutherland, S., MacKenzie, K., Reddel, R., Liu, J. (2024). Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia. Cancer Medicine, 13(6). [More Information]
Kienzl, P., Weber, G., Pirker, C., Laengle, S., Braunschmid, T., Dragona, E., Marian, B., Gagos, S., Lu, L., Henson, J., Lau, L., Reddel, R., et al (2024). Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression. Cellular Oncology. [More Information]

2023

Boys, E., Liu, J., Robinson, P., Reddel, R. (2023). Clinical applications of mass spectrometry-based proteomics in cancer: Where are we? Proteomics, 23(2023-08-07 00:00:00). [More Information]
Tuano, N., Beesley, J., Manning, M., Shi, W., Perlaza-Jimenez, L., Malaver-Ortega, L., Paynter, J., Black, D., Civitarese, A., McCue, K., Reddel, R., et al (2023). CRISPR screens identify gene targets at breast cancer risk loci. Genome Biology, 24(1). [More Information]
Poulos, R., Cai, Z., Robinson, P., Reddel, R., Zhong, Q. (2023). Opportunities for pharmacoproteomics in biomarker discovery. Proteomics, 23(7-8). [More Information]
Connolly, E., Grimison, P., Horvath, L., Robinson, P., Reddel, R. (2023). Quantitative proteomic studies addressing unmet clinical needs in sarcoma. Frontiers in Oncology, 13. [More Information]

show 1 more

2022

Holmes, O., Nones, K., Tang, Y., Loffler, K., Lee, M., Patch, A., Dagg, R., Lau, L., Leonard, C., Wood, S., Pickett, H., Reddel, R., et al (2022). qmotif: determination of telomere content from whole-genome sequence data. Bioinformatics Advances, 2(1). [More Information]
Reddel, R., Aref, A. (2022). Targeting brain cancer. Science, 377(6605), 467-468. [More Information]
de Nonneville, A., Salas, S., Bertucci, F., Sobinoff, A., Adélaïde, J., Guille, A., Finetti, P., Noble, J., Churikov, D., Chaffanet, M., Pickett, H., Reddel, R., et al (2022). TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. EMBO Molecular Medicine, 14(10). [More Information]

2021

de Nonneville, A., Reddel, R. (2021). Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX. Nature Communications, 12(1), 1552. [More Information]
Kaul, Z., Cheung, C., Bhargava, P., Sari, A., Yu, Y., Huifu, H., Bid, H., Henson, J., Groden, J., Reddel, R., et al (2021). Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells. Scientific Reports, 11(1), 17052. [More Information]
Chen, Y., Dagg, R., Zhang, Y., Lee, J., Lu, R., la Rotta, N., Sampl, S., Korkut-Demirbaş, M., Holzmann, K., Lau, L., Reddel, R., et al (2021). The c-circle biomarker is secreted by alternative-lengthening-of-telomeres positive cancer cells inside exosomes and provides a blood-based diagnostic for alt activity. Cancers, 13(21), 5369. [More Information]

2020

Reddel, R., MacKenzie, K., Bryan, T. (2020). End Products of Telomere Research. Cell Stem Cell, 26(6), 804-805. [More Information]
Kamata, T., So, T., Ahmed, Q., Giblett, S., Patel, B., Luo, J., Reddel, R., Pritchard, C. (2020). Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development. Cell Reports, 31(12), 107802. [More Information]
Eiholzer, R., Mehta, S., Kazantseva, M., Drummond, C., McKinney, C., Young, K., Slater, D., Morten, B., Avery-Kiejda, K., Lasham, A., Reddel, R., Huschtscha, L., et al (2020). Intronic TP53 polymorphisms are associated with increased change 133TP53 transcript, immune infiltration and cancer risk. Cancers, 12(9), 1-18. [More Information]
Wu, Y., Poulos, R., Reddel, R. (2020). Role of POT1 in Human Cancer. Cancers, 12(10), 1-19. [More Information]
Poulos, R., Hains, P., Shah, R., Lucas, N., Xavier, D., Manda, S., Anees, A., Koh, J., Mahboob, S., Wittman, M., Williams, S., Sykes, E., Hecker, M., Dausmann, M., Wouters, M., Yang, J., deFazio, A., Balleine, R., Tully, B., Reddel, R., Robinson, P., Zhong, Q., et al (2020). Strategies to enable large-scale proteomics for reproducible research. Nature Communications, 11(1), 3793. [More Information]

show 2 more

2019

Tully, B., Balleine, R., Hains, P., Zhong, Q., Reddel, R., Robinson, P. (2019). Addressing the Challenges of High-Throughput Cancer Tissue Proteomics for Clinical Application: ProCan. Proteomics, 19(21-22), 1-5. [More Information]
HAN, M., Napier, C., Frolich, S., Teber, E., Wong, T., Noble, J., Choi, E., Everett, R., Cesare, A., Reddel, R. (2019). Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency. Journal of Cell Science, 132(5), 1-10. [More Information]
Lu, R., O'Rourke, J., Sobinoff, A., Allen, J., Nelson, C., Tomlinson, C., Lee, M., Reddel, R., Deans, A., Pickett, H. (2019). The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT). Nature Communications, 10(1), 1-14. [More Information]

2018

Campbell, H., Fleming, N., Roth, I., Mehta, S., Wiles, A., Williams, G., Vennin, C., Arsic, N., Parkin, A., Pajic, M., Reddel, R., Braithwaite, A., et al (2018). delta133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling. Nature Communications, 9, 1-13. [More Information]
Nair, S., Luu, P., Qu, W., Maddugoda, M., Huschtscha, L., Reddel, R., Chenevix-Trench, G., Toso, M., Kench, J., Horvath, L., Hayes, V., Rasko, J., Wong, J., et al (2018). Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten. Epigenetics & Chromatin, 11(1), 1-20. [More Information]
Mehta, S., Morten, B., Anthony, J., Henderson, L., Lasham, A., Campbell, H., Cunliffe, H., Horsfield, J., Reddel, R., Avery-Kiejda, K., Braithwaite, A., et al (2018). Regulation of the interferon-gamma (IFN-y) pathway by p63 and 133p53 isoform in different breast cancer subtypes. Oncotarget, 9(49), 29146-29161. [More Information]
Lee, M., Teber, E., Holmes, O., Nones, K., Patch, A., Dagg, R., Lau, L., Lee, J., Napier, C., Arthur, J., Hayward, N., Mann, G., Scolyer, R., Wilmott, J., Reddel, R., Pickett, H., et al (2018). Telomere sequence content can be used to determine ALT activity in tumours. Nucleic Acids Research, 46, 4903-4918. [More Information]

show 1 more

2017

Sobinoff, A., Allen, J., Neumann, A., Yang, S., Walsh, M., Henson, J., Reddel, R., Pickett, H. (2017). BLM and SLX4 play opposing roles in recombination-dependent replication at human telomeres. EMBO Journal, 36(19), 2907-2919. [More Information]
Lee, M., Napier, C., Yang, F., Arthur, J., Reddel, R., Pickett, H. (2017). Comparative analysis of whole genome sequencing-based telomere length measurement techniques. Methods, 114, 4-15. [More Information]
Dagg, R., Pickett, H., Neumann, A., Napier, C., Henson, J., Teber, E., Arthur, J., Reynolds, C., Murray, J., Haber, M., Sobinoff, A., Lau, L., Reddel, R. (2017). Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres. Cell Reports, 19(12), 2544-2556. [More Information]
Helbig, S., Wockner, L., Bouendeu, A., Hille-Betz, U., McCue, K., French, J., Edwards, S., Pickett, H., Reddel, R., Chenevix-Trench, G., et al (2017). Functional dissection of breast cancer risk-associated TERT promoter variants. Oncotarget, 8(40), 67203-67217. [More Information]
Ginn, S., Hallwirth, C., Liao, S., Teber, E., Arthur, J., Wu, J., Lee, H., Tay, S., Hu, M., Reddel, R., Alexander, S., Alexander, I., et al (2017). Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency. Molecular Therapy - Nucleic Acids, 6, 1-14. [More Information]
Khushi, M., Napier, C., Smyth, C., Reddel, R., Arthur, J. (2017). MatCol: A tool to measure fluorescence signal colocalisation in biological systems. Scientific Reports, 7(1), 1-9. [More Information]
Henson, J., Lau, L., Koch, S., Martin La Rotta, N., Dagg, R., Reddel, R. (2017). The C-Circle Assay for Alternative-Lengthening-of-Telomeres activity. Methods, 114, 74-84. [More Information]
Scarpa, A., Chang, D., Nones, K., Corbo, V., Patch, A., Bailey, P., Lawlor, R., Johns, A., Miller, D., Lau, L., Lee, M., Pickett, H., Reddel, R., Samra, J., Kench, J., Gill, A., et al (2017). Whole-genome landscape of pancreatic neuroendocrine tumours. Nature, 543(7643), 65-71. [More Information]
Yu, Y., Katiyar, S., Sundar, D., Kaul, Z., Miyako, E., Zhang, Z., Kaul, S., Reddel, R., Wadhwa, R. (2017). Withaferin-A kills cancer cells with and without telomerase: Chemical, computational and experimental evidences. Cell Death and Disease, 8(4), 1-12. [More Information]

show 6 more

2016

Mehta, S., Tsai, P., Lasham, A., Campbell, H., Reddel, R., Braithwaite, A., Print, C. (2016). A study of TP53 RNA splicing illustrates pitfalls of RNA-seq methodology. Advances in Cancer Research, 76(24), 7151-7159. [More Information]
Novakovic, B., Napier, C., Vryer, R., Dimitriadis, E., Manuelpillai, U., Sharkey, A., Craig, J., Reddel, R., Saffery, R. (2016). DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta. Molecular Human Reproduction, 22(11), 791-799. [More Information]
Shannon, M., Capes-Davis, A., Eggington, E., Georghiou, R., Huschtscha-Holliday, L., Moy, E., Power, M., Reddel, R., Arthur, J. (2016). Is cell culture a risky business? Risk analysis based on scientist survey data. International Journal of Cancer, 138(3), 664-670. [More Information]
Barbaro, P., Ziegler, D., Reddel, R. (2016). The wide-ranging clinical implications of the short telomere syndromes. Internal Medicine Journal, 46(4), 393-403. [More Information]

show 1 more

2015

Killedar, A., Stutz, M., Sobinoff, A., Tomlinson, C., Bryan, T., Beesley, J., Chenevix-Trench, G., Reddel, R., Pickett, H. (2015). A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase. PLoS Genetics, 11(6), 1-23. [More Information]
Napier, C., Huschtscha-Holliday, L., Harvey, A., Bower, K., Noble, J., Hendrikson, E., Reddel, R. (2015). ATRX represses alternative lengthening of telomeres. Oncotarget, 6(18), 16543-16558. [More Information]
Locke, W., Zotenko, E., Stirzaker, C., Robinson, M., Hinshelwood, R., Stone, A., Reddel, R., Huschtscha, L., Clark, S. (2015). Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis. Clinical Epigenetics, 7(1), 1-15. [More Information]
Pickett, H., Reddel, R. (2015). Molecular mechanisms of activity and derepression of alternative lengthening of telomeres. Nature Structural and Molecular Biology, 22(11), 875-880. [More Information]
Pan, J., Huang, L., Belousova, T., Lu, L., Yang, Y., Reddel, R., Chang, A., Ju, H., DiMattia, G., Tong, Q., et al (2015). Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway. Journal of the American Society of Nephrology, 26(2), 364-378. [More Information]
Chang, A., Doherty, J., Huschtscha-Holliday, L., Redvers, R., Restall, C., Reddel, R., Anderson, R. (2015). STC1 expression is associated with tumor growth and metastasis in breast cancer. Clinical and Experimental Metastasis, 32(1), 15-27. [More Information]

show 3 more

2014

Guo, Y., Kartawinata, M., Li, J., Pickett, H., Teo, J., Kilo, T., Barbaro, P., Keating, B., Chen, Y., Tian, L., Al-Odaib, A., Reddel, R., Christodoulou, J., Bryan, T., et al (2014). Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood, 124(18), 2767-2774. [More Information]
Singh, R., Kalra, R., Hasan, K., Kaul, Z., Cheung, C., Huschtscha, L., Reddel, R., Kaul, S., Wadhwa, R. (2014). Molecular characterization of collaborator of ARF (CARF) as a DNA damage response and cell cycle checkpoint regulatory protein. Experimental Cell Research, 322(2), 324-334. [More Information]
Conomos, D., Reddel, R., Pickett, H. (2014). NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. Nature Structural and Molecular Biology, 21(9), 760-770. [More Information]
Gupta, R., Dong, Y., Solomon, P., Wettersten, H., Cheng, C., Min, J., Henson, J., Dogra, S., Hwang, S., Hammock, B., Reddel, R., et al (2014). Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A. Proceedings of the National Academy of Sciences of the United States of America, 111(30), E3062-E3071. [More Information]
Lee, M., Hills, M., Conomos, D., Stutz, M., Dagg, R., Lau, L., Reddel, R., Pickett, H. (2014). Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes. Nucleic Acids Research, 42(3), 1733-1746. [More Information]
Reddel, R. (2014). Telomere maintenance mechanisms in cancer: clinical implications. Current Pharmaceutical Design, 20(41), 6361-6374. [More Information]

show 3 more

2013

Neumann, A., Watson, C., Noble, J., Pickett, H., Tam, P., Reddel, R. (2013). Alternative lengthening of telomeres in normal mammalian somatic cells. Genes and Development, 27(1), 18-23. [More Information]
Conomos, D., Pickett, H., Reddel, R. (2013). Alternative lengthening of telomeres: remodeling the telomere architecture. Frontiers in Oncology, 3, 1-7. [More Information]
Lau, L., Dagg, R., Henson, J., Au, A., Royds, J., Reddel, R. (2013). Detection of alternative lengthening of telomeres by telomere quantitative PCR. Nucleic Acids Research, 41(2), 1-9. [More Information]
Bojesen, S., Pooley, K., Johnatty, S., Beesley, J., Michailidou, K., Tyrer, J., Edwards, S., Pickett, H., Shen, H., Smart, C., Stutz, M., Reddel, R., et al (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics, 45(4), 371-384. [More Information]
Durukan Tolvanen, A., Westberg, J., Serlachius, M., Chang, A., Reddel, R., Andersson, L., Tatlisumak, T. (2013). Stanniocalcin 1 is important for poststroke functionality, but dispensable for ischemic tolerance. Neuroscience, 229, 49-54. [More Information]
Pena, C., Cespedes, M., Lindh, M., Kiflemariam, S., Mezheyeuski, A., Edqvist, P., Hagglof, C., Birgisson, H., Bojmar, L., Jirstrom, L., Chang, A., Reddel, R., et al (2013). STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer. Cancer Research, 73(4), 1287-1297. [More Information]

show 3 more

2012

Shay, J., Reddel, R., Wright, W. (2012). Cancer and Telomeres - An ALTernative to Telomerase. Science, 336(6087), 1388-1390. [More Information]
Huschtscha-Holliday, L., Napier, C., Noble, J., Bower, K., Au, A., Campbell, H., Braithwaite, A., Reddel, R. (2012). Enhanced isolation of fibroblasts from human skin explants. BioTechniques, 53(4), 239-244. [More Information]
Bender, H., Murchison, E., Pickett, H., Deakin, J., Strong, M., Conlan, C., McMillan, D., Neumann, A., Greider, C., Hannon, G., Reddel, R., et al (2012). Extreme telomere length dimorphism in the Tasmanian devil and related marsupials suggests parental control of telomere length. PloS One, 7(9), 1-10. [More Information]
Kaul, Z., Cesare, A., Huschtscha-Holliday, L., Neumann, A., Reddel, R. (2012). Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Reports, 13(1), 52-59. [More Information]
Lovejoy, C., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., De Lange, T., De, S., Petrini, J., Sung, P., Jasin, M., Reddel, R., et al (2012). Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway. PLoS Genetics, 8(7), 1-16. [More Information]
Bower, K., Napier, C., Cole, S., Dagg, R., Lau, L., Duncan, E., Moy, E., Reddel, R. (2012). Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres. PloS One, 7(11), 1-10. [More Information]
Reddel, R. (2012). Senescence and immortalization. (Vol. 1, pp. 2697-2699).
Pickett, H., Reddel, R. (2012). The role of telomere trimming in normal telomere length dynamics. Cell Cycle, 11(7), 1309-1315. [More Information]
Conomos, D., Stutz, M., Hills, M., Neumann, A., Bryan, T., Reddel, R., Pickett, H. (2012). Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells. The Journal of Cell Biology, 199(6), 893-906. [More Information]

show 6 more

2011

Beesley, J., Pickett, H., Johnatty, S., Dunning, A., Chen, X., Li, J., Michailidou, K., Lu, Y., Rider, D., Palmieri, R., Stutz, M., Reddel, R., et al (2011). Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PloS One, 6(9), 1-6. [More Information]
Jiang, W., Nguyen, A., Cao, Y., Chang, A., Reddel, R. (2011). HP1-Mediated Formation of Alternative Lengthening of Telomeres-Associated PML Bodies Requires HIRA but Not ASF1a. PloS One, 6(2), e17036-1-e17036-12. [More Information]
Yoon, A., Gao, R., Kaul, Z., Choi, I., Ryu, J., Noble, J., Kato, Y., Saito, S., Hirano, T., Ishii, T., Reddel, R., et al (2011). MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region. Nucleic Acids Research, 39(18), 8078-8091. [More Information]
Pickett, H., Henson, J., Au, A., Neumann, A., Reddel, R. (2011). Normal mammalian cells negatively regulate telomere length by telomere trimming. Human Molecular Genetics, 20(23), 4684-4692. [More Information]
Au, A., Hackl, T., Yeager, T., Cohen, S., Pass, H., Harris, C., Reddel, R. (2011). Telomerase activity in pleural malignant mesotheliomas. Lung Cancer, 73(3), 283-288. [More Information]

show 2 more

2010

Cesare, A., Reddel, R. (2010). Alternative lengthening of telomeres: models, mechanisms and implications. Nature reviews. Genetics, 11(5), 319-30. [More Information]
Henson, J., Reddel, R. (2010). Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. FEBS Letters, 584(17), 3800-11. [More Information]
Capes-Davis, A., Atkin, I., Drexler, H., Kohara, A., Macleod, R., Masters, J., Nakamura, Y., Reid, Y., Reddel, R., Freshney, R. (2010). Check your cultures! A list of cross-contaminated or misidentified cell lines. International Journal of Cancer, 127(1), 1-8. [More Information]
McDonald, K., McDonnell, J., Muntoni, A., Henson, J., Hegi, M., von Deimling, A., Wheeler, H., Cook, R., Biggs, M., Little, N., Robinson, B., Reddel, R., et al (2010). Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival. Journal of Neuropathology and Experimental Neurology, 69(7), 729-736. [More Information]
Reddel, R. (2010). Senescence: an antiviral defense that is tumor suppressive? Carcinogenesis, 31(1), 19-26. [More Information]

show 2 more

2009

Hinshelwood, R., Melki, J., Huschtscha, L., Paul, C., Song, J., Stirzaker, C., Reddel, R., Clark, S. (2009). Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Human Molecular Genetics, 18(16), 3098-3109. [More Information]
Pickett, H., Reddel, R. (2009). Alternative lengthening of telomeres in human cells. In Keiko Hiyama (Eds.), Telomeres and Telomerase in Cancer, (pp. 127-148). New York: Springer. [More Information]
Pickett, H., Cesare, A., Johnston, R., Neumann, A., Reddel, R. (2009). Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO Journal, 28(7), 799-809. [More Information]
Henson, J., Cao, Y., Huschtscha-Holliday, L., Chang, A., Au, A., Pickett, H., Reddel, R. (2009). DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nature Biotechnology, 27(12), 1181-1185. [More Information]
Graham, J., Mote, P., Salagame, U., Van Dijk, J., Balleine, R., Huschtscha-Holliday, L., Reddel, R., Clarke, C. (2009). DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology, 150(7), 3318-3326. [More Information]
Jiang, W., Zhong, Z., Nguyen, A., Henson, J., Toouli, C., Braithwaite, A., Reddel, R. (2009). Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. The Journal of Cell Biology, 185(5), 797-810. [More Information]
Huschtscha-Holliday, L., Moore, J., Noble, J., Campbell, H., Royds, J., Braithwaite, A., Reddel, R. (2009). Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21WAF1/CIP1. Journal of Cell Science, 122(16), 2989-2995. [More Information]
Jiang, W., Henson, J., Neumann, A., Reddel, R. (2009). Protocol III: Detection of alternative lengthening of telomeres. In Keiko Hiyama (Eds.), Telomeres and Telomerase in Cancer, (pp. 351-364). New York: Springer. [More Information]
Cesare, A., Kaul, Z., Cohen, S., Napier, C., Pickett, H., Neumann, A., Reddel, R. (2009). Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions. Nature Structural and Molecular Biology, 16(12), 1244-1251. [More Information]
Nguyen, A., Chang, A., Reddel, R. (2009). Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress. Oncogene, 28(18), 1982-1992. [More Information]
Ng, L., Cropley, J., Pickett, H., Reddel, R., Suter, C. (2009). Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Research, 37(4), 1152-1159. [More Information]
Muntoni, A., Neumann, A., Hills, M., Reddel, R. (2009). Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres. Human Molecular Genetics, 18(6), 1017-1027. [More Information]
Yuan, J., Yang, B., Zhong, Z., Shatts, I., Milyavski, M., Rotter, V., Lock, R., Reddel, R., Mackenzie, K. (2009). Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase. Oncogene, 28(29), 2678-2689. [More Information]

show 10 more

2008

Cohen, S., Reddel, R. (2008). A sensitive direct human telomerase activity assay. Nature Methods, 5(4), 355-360. [More Information]
Cesare, A., Reddel, R. (2008). Alternative Lengthening of Telomeres in Mammalian Cells. In Josef Nosek and Lubomir Tomaska (Eds.), Origin and Evolution of Telomeres, (pp. 45-57). United States: Landes Biosciences.
Cao, Y., Huschtscha-Holliday, L., Nouwens, A., Pickett, H., Neumann, A., Chang, A., Toouli, C., Bryan, T., Reddel, R. (2008). Amplification of Telomerase Reverse Transcriptase Gene in Human Mammary Epithelial Cells with Limiting Telomerase RNA Expression Levels. Cancer Research, 68(9), 3115-3123. [More Information]
Cao, Y., Bryan, T., Reddel, R. (2008). Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Science, 99(6), 1092-1099. [More Information]
Villa, R., Daidone, M., Motta, R., Venturini, L., De Marco, C., Vannelli, A., Kusamura, S., Baratti, D., Deraco, M., Costa, A., Reddel, R., et al (2008). Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clinical Cancer Research, 14(13), 4134-4140. [More Information]
Chen, Y., Campbell, H., Wiles, A., Eccles, M., Reddel, R., Braithwaite, A., Royds, J. (2008). PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma. Cancer Research, 68(14), 5724-5732. [More Information]
Cesare, A., Reddel, R. (2008). Telomere uncapping and alternative lengthening of telomeres. Mechanisms of Ageing and Development, 129(1-2), 99-108. [More Information]
Chang, A., Hook, J., Lemckert, F., McDonald, M., Nguyen, M., Hardeman, E., Little, D., Gunning, P., Reddel, R. (2008). The murine stanniocalcin 2 gene is a negative regulator of postnatal growth. Endocrinology, 149(5), 2403-2410. [More Information]

show 5 more

2007

Reddel, R. (2007). A SUMO ligase for ALT. Nature Structural and Molecular Biology, 14(7), 570-571. [More Information]
Hinshelwood, R., Huschtscha-Holliday, L., Melki, J., Stirzaker, C., Abdipranoto, A., Vissel, B., Ravasi, T., Wells, C., Hume, D., Reddel, R., et al (2007). Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. Cancer Research, 67(24), 11517-11527. [More Information]
Zhong, Z., Jiang, W., Cesare, A., Neumann, A., Wadhwa, R., Reddel, R. (2007). Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. Journal of Biological Chemistry, 282(40), 29314-29322. [More Information]
Fasching, C., Neumann, A., Muntoni, A., Yeager, T., Reddel, R. (2007). DNA Damage Induces Alternative Lengthening of Telomeres (ALT) Associated Promyelocytic Leukemia Bodies that Preferentially Associate with Linear Telomeric DNA. Cancer Research, 67(15), 7072-7077. [More Information]
Jiang, W., Zhong, Z., Henson, J., Reddel, R. (2007). Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene, 26(32), 4635-4647. [More Information]
Cohen, S., Graham, M., Lovrecz, G., Bache, N., Robinson, P., Reddel, R. (2007). Protein composition of catalytically active human telomerase from immortal cells. Science, 315(5820), 1850-1853. [More Information]

show 3 more

2006

Chen, Y., Hakin-Smith, V., Teo, M., Xinarianos, G., Jellinek, D., Carroll, T., McDowell, D., MacFarlane, M., Boet, R., Baguley, B., Braithwaite, A., Reddel, R., et al (2006). Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma. Cancer Research, 66(13), 6473-6476. [More Information]
Neumann, A., Reddel, R. (2006). Telomerase independent maintenance of mammalian telomeres. In Titia De Lange, Vicki Lundblad, Elizabeth H. Blackburn (Eds.), Telomeres and Telomerase, (pp. 163-198). Michigan: Cold Spring Harbor Laboratory Press.
Costa, A., Daidone, M., Daprai, L., Villa, R., CantÃ¹, S., Pilotti, S., Mariani, L., Gronchi, A., Henson, J., Reddel, R., et al (2006). Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Research, 66(17), 8918-8924. [More Information]
Wadhwa, R., Takano, S., Kaur, K., Deocaris, C., Pereira-Smith, O., Reddel, R., Kaul, S. (2006). Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. International Journal of Cancer, 118(12), 2973-2980. [More Information]

show 1 more

2005

Henson, J., Hannay, J., McCarthy, S., Royds, J., Yeager, T., Robinson, R., Wharton, S., Jellinek, D., Arbuckle, S., Yoo, J., Robinson, B., Learoyd, D., Reddel, R., et al (2005). A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clinical Cancer Research, 11(1), 217-225. [More Information]
Jeyapalan, J., Varley, H., Foxon, J., Pollock, R., Jeffreys, A., Henson, J., Reddel, R., Royle, N. (2005). Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome. Human Molecular Genetics, 14(13), 1785-1794. [More Information]
Moran-Jones, K., Wayman, L., Kennedy, D., Reddel, R., Sara, S., Snee, M., Smith, R. (2005). hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Research, 33(2), 486-496. [More Information]
Jiang, W., Zhong, Z., Henson, J., Neumann, A., Chang, A., Reddel, R. (2005). Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex. Molecular and Cellular Biology, 25(7), 2708-2721. [More Information]
Fasching, C., Bower, K., Reddel, R. (2005). Telomerase-Independent Telomere Length Maintenance in the Absence of Alternative Lengthening of Telomeresâ€“Associated Promyelocytic Leukemia Bodies. Cancer Research, 65(7), 2722-2729. [More Information]
Muntoni, A., Reddel, R. (2005). The first molecular details of ALT in human tumor cells. Human Molecular Genetics, 14(Review Issue 2), R191-R196. [More Information]
Chang, A., Cha, J., Koentgen, F., Reddel, R. (2005). The murine stanniocalcin 1 gene is not essential for growth and development. Molecular and Cellular Biology, 25(23), 10604-10610. [More Information]

show 4 more

2004

Noble, J., Zhong, Z., Neumann, A., Melki, J., Clark, S., Reddel, R. (2004). Alterations In The P16(Ink4A) And P53 Tumor Suppressor Genes Of Htert-Immortalized Human Fibroblasts. Oncogene, 23(17), 3116-3121. [More Information]
Londono-Vallejo, J., Der-Sarkissian, H., Cazes, L., Bacchetti, S., Reddel, R. (2004). Alternative Lengthening Of Telomeres Is Characterized By High Rates Of Telomeric Exchange. Cancer Research, 64(7), 2324-2327. [More Information]
Colgin, L., Reddel, R. (2004). Telomere Biology: A New Player In The Dispatch End Zone. Current Biology, 14(20), R901-R902. [More Information]

2003

Hakin-Smith, V., Jellinek, D., Levy, D., Carroll, T., Teo, M., Timperley, W., McKay, M., Reddel, R., Royds, J. (2003). Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. The Lancet, 361(9360), 836-838. [More Information]
Reddel, R. (2003). Alternative lengthening of telomeres, telomerase and cancer. Cancer Letters, 194(2), 155-162. [More Information]
Reddel, R., Bryan, T. (2003). Alternative lengthening of telomeres: dangerous road less travelled. The Lancet, 361(9372), 1840-1841. [More Information]
Colgin, L., Baran, K., Baumann, P., Cech, T., Reddel, R. (2003). Human POT1 facilitates telomere elongation by telomerase. Current Biology, 13(11), 942-946. [More Information]
Chang, A., Jellinek, D., Reddel, R. (2003). Mammalian stanniocalcins and cancer. Endocrine-Related Cancer, 10(3), 359-373. [More Information]
Kaul, S., Yaguchi, T., Taira, K., Reddel, R., Wadhwa, R. (2003). Overexpressed mortalin (mot-2)/mthsp70/GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts. Experimental Cell Research, 286(1), 96-101. [More Information]
Toouli, C., Reddel, R. (2003). Telomeres and cellular ageing. In S.C. Kaul and R. Wadhwa (Eds.), Aging of Cells In and Outside the Body, (pp. 171-205). US: Kluwer Academic Publishers.

show 4 more

2002

Wadhwa, R., Sugihara, T., Hasan, M., Taira, K., Reddel, R., Kaul, S. (2002). A Major Functional Difference between the mouse and Human ARF Tumor Suppressor proteins. Journal of Biological Chemistry, 277(39), 36665-36670. [More Information]
Henson, J., Neumann, A., Yeager, T., Reddel, R. (2002). Alternative lengthening of telomeres in mammalian cells. Oncogene, 21(4), 598-610. [More Information]
Toouli, C., Huschtscha-Holliday, L., Neumann, A., Noble, J., Colgin, L., Hukku, B., Reddel, R. (2002). Comparison of human mammary epithelial cells immortalized by simian virus 40 T-antigen or by the telomerase catalytic subunit. Oncogene, 21(1), 128-139. [More Information]
Wadhwa, R., Yaguchi, T., Hasan, M., Mitsui, Y., Reddel, R., Kaul, S. (2002). Hsp70 Family Member, mot-2/mthsp70/GRP75, binds to the Cytoplasmic Sequestration Domain of the P53 Gene. Experimental Cell Research, 274(2), 246-253. [More Information]
Varley, H., Pickett, H., Foxon, J., Reddel, R., Royle, N. (2002). Molecular characterisation of inter-telomere and intra-telomere mutations in human ALT cells. Nature Genetics, 30(3), 301-305. [More Information]
Wadhwa, R., Colgin, L., Yaguchi, T., Taira, K., Reddel, R., Kaul, S. (2002). Rhodacyanine Dye MKT-077 Inhibits in Vito Telomerase Assay but has no detectable effects on Telomerase activity in vivo. Cancer Research, 62(15), 4434-4438.
Bouras, T., Southey, M., Chang, A., Reddel, R., Willhite, D., Glynne, R., Henderson, M., Armes, J., Venter, D. (2002). Stanniocalcin 2 is an estorgen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Research, 62(5), 1289-1295.
Neumann, A., Reddel, R. (2002). Telomere maintenance and cancer - look, no Telomerase. Nature Reviews Cancer, 2(11), 879-884. [More Information]
Fasching, C., Reddel, R. (2002). Telomere maintenance in human cell lines and tumors without telomerase. In Guido Krupp and Reza Parwaresch (Eds.), Telomeres and telomerases: Cancer and Biology, (pp. 359-373). Georgetown, Texas, USA: Landes Biosciences.

show 6 more

2001

Reddel, R., Bryan, T., Colgin, L., Perrem, K., Yeager, T. (2001). Alternative lengthening of telomeres in human cells. Radiation Research, 155(1), 194-200. [More Information]
Reddel, R. (2001). An alternative lifestyle for immortalized oral keratinocytes. Journal of Clinical Investigation, 108, 665-667.
Reddel, R., Kaul, S., Mitsui,, Y., Wadhwa, R. (2001). An N-Terminal Region of Mot-2 Binds to p53 In Vitro. Neoplasia (Spanish Edition): oncologia multidisciplinaria, 3, 110-114.
Perrem, K., Colgin, L., Neumann,, A., Yeager, T., Reddel, R. (2001). Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells. Molecular and Cellular Biology, 21, 3862-3875.
Reddel, R., Huschtscha, L., Neumann,, A., Noble,, J. (2001). Effects of Simian Virus 40 T-Antigens on Normal Human Mammary Epithelial Cells Reveal Evidence for Spontaneous Alterations in Addition to Loss of P16INK4a Expression. Experimental Cell Research, 265, 125-134.
Reddel, R., Sugihara, T., Kaul, S., Kato, J., Nomura, H., Wadhwa, R. (2001). Pex19p Dampens the p19ARF-p53-p21WAF1 Tumor Suppressor Pathway. Journal of Biological Chemistry, 276, 18649-18652.
Reddel, R., Szutorisz, H., Palmqvist, R., Roos, G., Stenling,, R., Schorderet, D., Linger,, J., Nabholz,, M. (2001). Rearrangements of minisatelites in the human telomerase reverse transcriptase gene are not correlated with its expression in colon carcinomas. Oncogene, 20, 2600-2605.

show 4 more

Selected Grants

2022

DEVELOPMENT OF PHOTORECEPTOR CELL THERAPY TO TREAT BLINDNESS, Elwood N, Gonzalez Cordero A, Wakefield C, Yang P, Hetherington K, Jamieson R, Reddel R, Simunovic M, Tam P, Grigg J, Zreiqat H, Department of Health and Aged Care (Federal - administered by NHMRC)/2021 MRFF Stem Cell Therapies Mission

2021

Accelerating paediatric cancer precision medicine with mass spectrometry-based proteomics, Poulos R, Reddel R, Zhong Q, Robinson P, Cowley M, Lau L, Ziegler D, Balleine R, National Health and Medical Research Council (NHMRC)/Ideas Grant
The APRICA program- Accelerated translational research in PRImary Liver Cancer, George J, McCaughan G, Reddel R, Bertolino P, Palendira M, Eslam M, Usherwood T, Cancer Institute NSW/Accelerated Translational Research Grant
Alternative Lengthening of Telomeres (ALT): Target Discovery to Treatment, Pickett H, Cesare A, Reddel R, Lau Y, Department of Health and Aged Care (Federal)/MRFF - 2020 Childhood Cancer Research Grant

2019

PPM Project 3: Improved understanding of the role of genetic predisposition in childhood cancer through prospective analyses of NSW patients, Reddel R, Byrne J, Dalla-Pozza L, Health Administration Corporation/Research Grant
Paediatric Precision Medicine Computational Biology Project, Reddel R, Health Administration Corporation/Research Grant

2018

ProCan : The human cancer proteome project - Part 1, Reddel R, Department of Health and Aged Care (Federal)/MRFF - Genomic Health Futures Mission (GHFM) - Procan
NSW Cancer Research Peptide Synthesis Facility, Reddel R, Cancer Institute NSW/Equipment Grant
Proteomics data platform for collaborative research and treatment-decision support, Reddel R, Robinson P, Zhong Q, Balleine R, Harnett P, Dalla-Pozza L, Cancer Council NSW/Infrastructure Development Grant

2017

Biotage Syro II Automated Parallel Peptide Synthesizer from Shimadzu Scientific Instruments (oceania) Pty Ltd., Robinson P, Payne R, Reddel R, National Health and Medical Research Council (NHMRC)/Equipment Grant
DGM70 Single-sided Individually Ventilated Cage (IVC) racks, associated cages, air handling unit and change station - equipment for a human xenograft mouse facility, Alexander I, Lisowski L, Reddel R, National Health and Medical Research Council (NHMRC)/Equipment Grant
Using proteomics to transform treatment decisions for breast cancer, Reddel R, Balleine R, Robinson P, National Breast Cancer Foundation/Investigator Initiated Research Scheme
Transforming protein quantitation technology to improve cancer diagnosis and treatment decisions, Reddel R, Robinson P, Balleine R, Bowling F, Dalla Pozza L, deFazio A, Harnett P, Mann G, Morton R, Spillane A, Cancer Institute NSW/Translational Program Grant
BD FACSymphony A5 High Parameter Flow Cytometer for Westmead Research Hub at Westmead Precinct, Mann G, deFazio A, Bendall L, George J, Gottlieb D, Clarke C, Byrne J, Shaw P, Reddel R, Ling S, Cancer Institute NSW/Equipment Grant

2016

Kids Cancer Alliance (KCA), Marshall G, Reddel R, Cancer Institute NSW/Translational Cancer Research Centre

2015

Barocycler Pressure Cycling Technology, Robinson P, Reddel R, Byrne J, Cooper S, deFazio A, National Health and Medical Research Council (NHMRC)/Equipment Grant
Role of variant telomere repeats in normal biology and abnormal ageing , Reddel R, DVC Research/Bridging Support Grant
G-quadruplex DNA: a molecular target for treatment of cancers using the alternative lengthening of telomeres (ALT) mechanism., Reddel R, Bryan T, Cancer Council NSW/Priority-driven Collaborative Cancer Research Scheme
CellBank Australia: improving the quality, reproducibility and credibility of cell culture-based preclinical cancer research, Reddel R, Cancer Institute NSW/Research Infrastructure Grant

2014

ALT-associated PML Bodies: Keys to the biology and treatment of an important subset of cancers, Reddel R, National Health and Medical Research Council (NHMRC)/Project Grants
High content screening (HCS) in-cell imaging system , Robinson P, Chircop (nee Fabbro) M, Reddel R, Bryan T, Cesare A, DVC Research/Equipment Grant
Telomere length analysis for assessing risk of melanoma, other cancers and chronic diseases $150,000, Reddel R, DVC Research/HMR+ Implementation Fund - MRI

2013

Activation of TERT in breast cancer, Reddel R, Beesley J, French J, Pickett H, Huschtscha-Holliday L, Cloonan N, National Health and Medical Research Council (NHMRC)/Project Grants
Automated in situ analysis capacity for translational cancer research, Byrne J, Reddel R, Haber M, Norris M, deFazio A, Cancer Institute NSW/Equipment Grant

2012

Molecular characterisation of telomere trimming and its role in cell proliferative capacity, Reddel R, Pickett H, National Health and Medical Research Council (NHMRC)/Project Grants
A novel mechanism for sustained proliferation of cancer cells, Reddel R, Lau L, National Health and Medical Research Council (NHMRC)/Project Grants
Fluidigm BioMark HD - HX, Alexander I, Byrne J, Catchpoole D, Chircop (nee Fabbro) M, Jamieson R, Reddel R, Tam P, Robinson P, Bryan T, Diefenbach R, National Health and Medical Research Council (NHMRC)/Equipment Grant

2011

Interaction of TRF2 with DNA repair proteins in Alternative Lengthening of Telomeres, Braithwaite A, Lau L, Reddel R, National Health and Medical Research Council (NHMRC)/Project Grants

2010

The BD Influx High Speed Cell Sorter, Cunningham A, George J, Rizos H, Clarke C, Reddel R, Kefford R, North K, Stewart G, Jones C, Tam P, Alexander S, Gottlieb D, Bradstock K, Bryan T, Booth D, Bendall L, Brilot-Turville F, Hebbard L, Cooper S, Wang Y, Wang X, National Health and Medical Research Council (NHMRC)/Equipment Grant
Telomere structural abnormalities in cells using alternative lengthening of teleomeres, Reddel R, Pickett H, National Health and Medical Research Council (NHMRC)/Project Grants

2009

Westmead Correlative Light and Electron Microscope Suite, North K, Jones C, Christodoulou J, Murray R, O'Neill G, Cantrill L, Cunningham A, Kefford R, Clarke C, Henderson B, Bendall L, Turville S, Reddel R, Tam P, Robinson P, Bryan T, Braithwaite A, National Health and Medical Research Council (NHMRC)/Equipment Grant
Induction of senescence in cells that use the Alternative Lengthening of Telomeres (ALT) mechanism, Reddel R, National Health and Medical Research Council (NHMRC)/Project Grants
Role of STC1 and STC2 in breast carcinogenesis, Reddel R, Chang A, National Health and Medical Research Council (NHMRC)/Project Grants

2008

Deltavision (DV) Core Image Restoration, Cunningham A, Turville S, Clarke C, Henderson B, Kefford R, North K, O'Neill G, Murray R, Reddel R, Tam P, Robinson P, Chircop M, National Health and Medical Research Council (NHMRC)/Equipment Grant

2006

Flow Cytometry support, Alexander S, Bendall L, Bradstock K, Braithwaite A, Byrne J, Gunning P, Henderson B, Jones C, Kefford R, Reddel R, Rizos H, Cancer Institute NSW/Infrastructure Grant

Faculty of Medicine and Health

Page not found

Professor Roger Reddel

Publications

By Type

By Year

Selected Grants

2022

2021

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2006

Related research articles

Academics awarded $4.6 million to conduct vital cancer research

Nine University scholars named AAHMS Fellows

Early career female researchers shine in cancer fellowships

Roger Reddel wins Neil Hamilton Fairley Medal

Cancer Moonshot: new deal to accelerate detection and treatment of cancer

$10 million grant awarded for bold new vision in cancer research